1-20 of 25
Li Yu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT173: Preliminary results from a phase I study of IMM0306 in patients with relapsed or refractory CD20-positive B-cell non-Hodgkin's lymphoma

Yuankai Shi, Jianliang Yang, Yongping Song, Keshu Zhou, Zhiming Li, Mingzhi Zhang, Hongmei Jing, Zhen Wang, Li Yu, Qiying Lu, Frank Gan, Wenzhi Tian
Journal: Cancer Research
Cancer Res (2024) 84 (7_Supplement): CT173.
https://doi.org/10.1158/1538-7445.AM2024-CT173
Published: 05 April 2024
View article titled, Abstract CT173: Preliminary results from a phase I study of IMM0306 in patients with relapsed or refractory CD20-positive B-cell non-Hodgkin's lymphoma
Journal Articles

Abstract CT008: Pembrolizumab (pembro) in combination with gemcitabine and cisplatin (gem/cis) for advanced biliary tract cancer (BTC): Phase 3 KEYNOTE-966 study

Robin Kate Kelley, Changhoon Yoo, Richard S. Finn, Junji Furuse, Zhenggang Ren, Thomas Yau, Heinz-Josef Klümpen, Stephen Lam Chan, Arndt Vogel, Masato Ozaka, Chris Verslype, Mohamed Bouattour, Joon Oh Park, Olga Barajas, Uwe Pelzer, Juan W. Valle, Li Yu, Usha Malhotra, Abby B. Siegel, Julien Edeline, Makoto Ueno
Journal: Cancer Research
Cancer Res (2023) 83 (8_Supplement): CT008.
https://doi.org/10.1158/1538-7445.AM2023-CT008
Published: 29 May 2023
View article titled, Abstract CT008: Pembrolizumab (pembro) in combination with gemcitabine and cisplatin (gem/cis) for advanced biliary tract cancer (BTC): Phase 3 KEYNOTE-966 study
Journal Articles

Abstract 3894: Determination of the efficacious Entrectinib exposures required for pathway inhibition and anti-tumor activity in a subcutaneous and intracranialTPM3-NTRK1mutant tumor model

Cecile C. de la Cruz, Thomas Hunsaker, Faye Vazvaei, Dragomir Draganov, Li Yu, Mark Merchant
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 3894.
https://doi.org/10.1158/1538-7445.AM2019-3894
Published: 01 July 2019
View article titled, Abstract 3894: Determination of the efficacious Entrectinib exposures required for pathway inhibition and anti-tumor activity in a subcutaneous and intracranial<em>TPM3-NTRK1</em>mutant tumor model
Journal Articles

hPCL3s Promotes Hepatocellular Carcinoma Metastasis by Activating β-Catenin Signaling

Zhen Cai, Zhen-Yu Qian, Hao Jiang, Ning Ma, Zhi Li, Li-Yu Liu, Xin-Xin Ren, Yu-Rong Shang, Jing-Jing Wang, Jing-Jing Li, Dong-Ping Liu, Xiu-Ping Zhang, Dan Feng, Qian-Zhi Ni, Yuan-Yuan Feng, Nan Li, Xiao-Yan Zhou, Xiang Wang, Ying Bao, Xue-Li Zhang, Yue-Zhen Deng, Dong Xie
Journal: Cancer Research
Cancer Res (2018) 78 (10): 2536–2549.
https://doi.org/10.1158/0008-5472.CAN-17-0028
Published: 14 May 2018
View article titled, hPCL3s Promotes Hepatocellular Carcinoma Metastasis by Activating β-Catenin Signaling
Open the PDF for hPCL3s Promotes Hepatocellular Carcinoma Metastasis by Activating β-Catenin Signaling in another window
Includes: Supplementary data
Journal Articles

Abstract 626: Application of patient-derived xenograft model in nasopharyngeal carcinoma research

Cheng-Lung Hsu, Yung-Chia Kuo, Yenlin Huang, Yin-Cheng Huang, Kar-Wai Lui, Kai-Ping Chang, Tung-Liang Lin, Hsien-Chi Fan, An-Chi Lin, Chia-Hsun Hsieh, Li-Yu Lee, Hung-Ming Wang, Hsin-Pai Li, Angel Chao, Yu-Sun Chang
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 626.
https://doi.org/10.1158/1538-7445.AM2016-626
Published: 15 July 2016
View article titled, Abstract 626: Application of patient-derived xenograft model in nasopharyngeal carcinoma research
Journal Articles

Abstract 3338: DLK1 could be a potential target against the cancer stem/progenitor cells of hepatocellular carcinoma

Xiao Xu, Xin Zhang, Rui-Fang Liu, Li-Yu Huang, Fei Chen, Ze-guang Han
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 3338.
https://doi.org/10.1158/1538-7445.AM10-3338
Published: 15 April 2010
View article titled, Abstract 3338: DLK1 could be a potential target against the cancer stem/progenitor cells of hepatocellular carcinoma
Journal Articles

Evaluation of the Proteasome Inhibitor MLN9708 in Preclinical Models of Human Cancer

Erik Kupperman, Edmund C. Lee, Yueying Cao, Bret Bannerman, Michael Fitzgerald, Allison Berger, Jie Yu, Yu Yang, Paul Hales, Frank Bruzzese, Jane Liu, Jonathan Blank, Khristofer Garcia, Christopher Tsu, Larry Dick, Paul Fleming, Li Yu, Mark Manfredi, Mark Rolfe, Joe Bolen
Journal: Cancer Research
Cancer Res (2010) 70 (5): 1970–1980.
https://doi.org/10.1158/0008-5472.CAN-09-2766
Published: 28 February 2010
View article titled, Evaluation of the Proteasome Inhibitor MLN9708 in Preclinical Models of Human Cancer
Open the PDF for Evaluation of the Proteasome Inhibitor MLN9708 in Preclinical Models of Human Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract #5636: Preclinical evaluation of the orally active proteasome inhibitor MLN9708 in preclinical models of human cancer

Erik Kupperman, Allison Berger, Li Yu, Christopher Tsu, Bruzzese Frank, Jane Liu, Jonathan Blank, Dick Larry, Fleming Paul, Cao Yueying, Bret Bannerman, Mike Fitzgerald, Julie Zhang, Jie Yu, Paul Hales, Mark Manfredi, Joe Bolen, Mark Rolfe
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 5636.
Published: 01 May 2009
View article titled, Abstract #5636: Preclinical evaluation of the orally active proteasome inhibitor MLN9708 in preclinical models of human cancer
Journal Articles

Abstract #3724: Antitumor activity of the Aurora A inhibitor MLN8237 in combination with Docetaxel in xenograft models of breast and prostate cancer

Jessica Huck, Mengkun Zhang, Marc Hyer, Li Yu, Bradley Stringer, Yu Yang, Jeffrey Ecsedy, Mark Manfredi
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 3724.
Published: 01 May 2009
View article titled, Abstract #3724: Antitumor activity of the Aurora A inhibitor MLN8237 in combination with Docetaxel in xenograft models of breast and prostate cancer
Journal Articles

Abstract #2921: Pharmacokinetics and pharmacodynamics of a selective proteasome inhibitor MLN9708 in nonclinical species following either intravenous or oral administration

Li Yu, Alex Bulychev, Lisa O'Brien, William Riorden, Shaoxia Yu, Martin Paton, Kym Cardoza, Bret Bannerman, Erik Kupperman
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 2921.
Published: 01 May 2009
View article titled, Abstract #2921: Pharmacokinetics and pharmacodynamics of a selective proteasome inhibitor MLN9708 in nonclinical species following either intravenous or oral administration
Journal Articles

Aflatoxin B1 exposure, hepatitis B virus infection and hepatocellular carcinoma in Taiwan

Hui-Chen Wu, Qiao Wang, Hwai-I Yang, Habibul Ahsan, Wei-Yann Tsai, Li-Yu Wang, Shu-Yuan Chen, Chien-Jen Chen, Regina M. Santella
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 1050.
Published: 01 May 2008
View article titled, Aflatoxin B<sub>1</sub> exposure, hepatitis B virus infection and hepatocellular carcinoma in Taiwan
Journal Articles

Study and compare the preventive effect of tocopherols and tocotrienols on epoxidation of aflatoxin B1 (AFB1) and estrone (E1)

Fu-Li Yu, Abdul Gapor, Wanda Bender, Katarzyna Berbeka
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 5465.
Published: 01 May 2008
View article titled, Study and compare the preventive effect of tocopherols and tocotrienols on epoxidation of aflatoxin B1 (AFB1) and estrone (E1)
Journal Articles

Pharmacodynamic/pharmacokinetic/efficacy relationships of MLN8237, a small-molecule inhibitor of Aurora A kinase

Arijit Chakravarty, Li Yu, Jessica Huck, Mengkun Zhang, Kristine Burke, Katherine Galvin, Bradley Stringer, Todd Sells, Christopher Claiborne, Mark Manfredi
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 4770.
Published: 01 May 2008
View article titled, Pharmacodynamic/pharmacokinetic/efficacy relationships of MLN8237, a small-molecule inhibitor of Aurora A kinase
Journal Articles

Control of Androgen Receptor Signaling in Prostate Cancer by the Cochaperone Small Glutamine–Rich Tetratricopeptide Repeat Containing Protein α

Grant Buchanan, Carmela Ricciardelli, Jonathan M. Harris, Jennifer Prescott, Zoe Chiao-Li Yu, Li Jia, Lisa M. Butler, Villis R. Marshall, Howard I. Scher, William L. Gerald, Gerhard A. Coetzee, Wayne D. Tilley
Journal: Cancer Research
Cancer Res (2007) 67 (20): 10087–10096.
https://doi.org/10.1158/0008-5472.CAN-07-1646
Published: 17 October 2007
View article titled, Control of Androgen Receptor Signaling in Prostate Cancer by the Cochaperone Small Glutamine–Rich Tetratricopeptide Repeat Containing Protein α
Open the PDF for Control of Androgen Receptor Signaling in Prostate Cancer by the Cochaperone Small Glutamine–Rich Tetratricopeptide Repeat Containing Protein α in another window
Includes: Supplementary data
Journal Articles

Baseline levels of urinary 15-F2t-isoprostane, and c     hronic h     epatitis B virus Infection in relation to risk of hepatocellular carcinoma in     Taiwan

Hui-Chen Wu, Qiao Wang, Lian-Wen Wang, Hwai-I Yang, Habibul Ahsan, Wei-Yann Tsai, Li-Yu Wang, Shu-Yuan Chen, Chien-Jen Chen, Regina M. Santella
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 1737.
Published: 01 May 2007
View article titled, Baseline levels of urinary 15-F<sub>2t</sub>-isoprostane, and c     hronic h     epatitis B virus Infection in relation to risk of hepatocellular carcinoma in     Taiwan
Journal Articles

Compare the preventive effect of alpha-tocopherol, alpha-, gamma-, and delta-tocotrienols on the formation of aflatoxin B1 (AFB1) epoxide and the potential to prevent liver cancer carcinogenesis at the initiation

Fu-Li Yu, Abdul Gapor, Wanda Bender, Katarzyna Berbaka
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 14.
Published: 01 May 2007
View article titled, Compare the preventive effect of alpha-tocopherol, alpha-, gamma-, and delta-tocotrienols on the formation of aflatoxin B1 (AFB1) epoxide and the potential to prevent liver cancer carcinogenesis at the initiation
Journal Articles

Human Kallikrein 8 Protease Confers a Favorable Clinical Outcome in Non–Small Cell Lung Cancer by Suppressing Tumor Cell Invasiveness

Yuh-Pyng Sher, Cheng-Chung Chou, Ruey-Hwang Chou, Han-Ming Wu, Wun-Shaing Wayne Chang, Chun-Houh Chen, Pan-Chyr Yang, Cheng-Wen Wu, Chia-Li Yu, Konan Peck
Journal: Cancer Research
Cancer Res (2006) 66 (24): 11763–11770.
https://doi.org/10.1158/0008-5472.CAN-06-3165
Published: 18 December 2006
View article titled, Human Kallikrein 8 Protease Confers a Favorable Clinical Outcome in Non–Small Cell Lung Cancer by Suppressing Tumor Cell Invasiveness
Open the PDF for Human Kallikrein 8 Protease Confers a Favorable Clinical Outcome in Non–Small Cell Lung Cancer by Suppressing Tumor Cell Invasiveness in another window
Includes: Supplementary data
Journal Articles

Baseline levels of urinary 8-oxodeoxyguanosine and hepatocellular carcinoma risk

Hui-Chen Wu, Qiao Wang, Lian-Wen Wang, Hwai-I Yang, Li-Yu Wang, Shu-Yuan Chen, Habibul Ahsan, Wei-Yann Tsai, Chien-Jen Chen, Regina M. Santella
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 217–218.
Published: 15 April 2006
View article titled, Baseline levels of urinary 8-oxodeoxyguanosine and hepatocellular carcinoma risk
Journal Articles

Genetic polymorphism of glutathione S-transferases M1 and T1, aflatoxin- and PAH-albumin adduct formation, and risk of hepatocellular carcinoma in Taiwan

Hui-Chen Wu, Chien-Jen Chen, Li-Yu Wang, Qaio Wang, Habibul Ahsan, Wei-Yann Tsai, Regina M. Santella
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 763–764.
Published: 01 May 2005
View article titled, Genetic polymorphism of glutathione S-transferases M1 and T1, aflatoxin- and PAH-albumin adduct formation, and risk of hepatocellular carcinoma in Taiwan
Journal Articles

Studies on the chemopreventive potentials of a marine lipid extract, Frondanol®, against breast cancer carcinogenesis at the initiation.

Fu-Li Yu, Peter Collin, Wanda Bender, Kiyoshi Yamaguchi, Bin Hu Xue
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 726.
Published: 01 April 2004
View article titled, Studies on the chemopreventive potentials of a marine lipid extract, Frondanol®, against breast cancer carcinogenesis at the initiation.